18 Dec, 2024 Navigating the Complex Landscape: Bona Fide Service Fees, Government Price Reporting, and the Inflation Reduction Act By CJ DeKreek “Manufacturers are responsible for meeting all four parts of the definition of bona fide service fee before a fee can qualify as a bona...
12 Nov, 2024 Artificial Intelligence: DOJ Update to the Evaluation of Corporate Compliance Programs By Ana Simon Lisa Taylor On Sept. 23, the U.S. Department of Justice (DOJ) updated its Evaluation of Corporate Compliance Programs (ECCP)1 guidance document for...
07 Oct, 2024 Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q2 2024] By Anthony Metke Robert Mundy Chamira Jayamanne Vin Phan Julie DeLong +2 more... Show less Ankura is pleased to present an overview of healthcare services transactions announced or closed during Q2 2024 in the United States....
16 Sep, 2024 CMS Proposes Protocols for Enhanced Oversight of Medicare Part C Utilization Management Requirements By Kelli Howe In 2024, the Centers for Medicare & Medicaid Services (CMS) leveraged its existing oversight channels1 to assess plans’ compliance with...
10 Sep, 2024 Leading the ASC Market: Advanced Strategies for Health Systems to Stay Ahead By Erin Nelson Katie Reilley Michelle Mader Between 2023 and 2030, the ambulatory surgery market in the U.S. is expected to grow by nearly 50%, increasing from a market value of $40...
09 Sep, 2024 Is there room for AI in the ICU? Guiding Principles and Compliance Considerations By Emily Petersen Lisa Taylor Jacqueline Voss Introduction Artificial Intelligence (AI) offers unprecedented opportunities to enhance patient care, streamline clinical documentation,...
04 Sep, 2024 Cross-Industry Insights: Learning From Consolidation Beyond Healthcare By Valerie Hart Jon Henrich Merrill Bohren Michelle Mader Erin Nelson +2 more... Show less Watch the on-demand recording of the latest panel discussion from Ankura that showcases how consolidation trends among hospital providers...
03 Sep, 2024 The Impact of the Proposed 2025 Physician Fee Schedule on Parity and Delivery By Angela Sabbe Healthcare in the United States is undergoing significant changes, particularly in the areas of reimbursement and coverage of telehealth,...
17 Jul, 2024 FDA Will Now Regulate Laboratory Developed Tests By Darri Scalzo On April 29, 2024, the Food and Drug Administration (FDA) announced a final rule to consider laboratory-developed tests (LDTs) to be...
07 Jun, 2024 Are You Paying Attention to Prior Authorization? Your Regulators Are. By Jeffrey Low Dorothy DeAngelis Kelli Howe Richard Merino Angela Sabbe +2 more... Show less With recent CMS mandates and state-level reforms, the healthcare industry faces a pivotal moment to improve prior authorization...
29 May, 2024 Pursuing Economies of Scale in Healthcare By Katie Reilley Erin Nelson Michelle Mader Lately, we have read about mega-scale hospital mergers and acquisitions (M&A) nearly every week. With M&A activity at the highest level...
14 May, 2024 Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q1 2024] By Anthony Metke Robert Mundy Ankura is pleased to present an overview of healthcare transactions announced or closed during Q1 2024 in the United States. Total...